Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
about
Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosisRifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TBRisk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisTreatment of Drug Susceptible Pulmonary TuberculosisThe rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort studyEfficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled TrialEfficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis.Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.Estimated rates of recurrence, cure, and treatment abandonment in patients with pulmonary tuberculosis treated with a -four-drug fixed-dose combination regimen at a tertiary health care facility in the city of Rio de Janeiro, Brazil.Clinical treatment outcomes of tuberculosis treated with the basic regimen recommended by the Brazilian National Ministry of Health using fixed-dose combination tablets in the greater metropolitan area of Goiânia, BrazilAdherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis.Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea.Changing from single-drug to fixed-dose combinations: experience from Fiji.Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trialTreating tuberculosis: time to introduce fixed-dose drug combinations.Relative bioavailability of rifampicin in four Chinese fixed-dose combinations compared with rifampicin in free combinations.Reflections on tuberculosis diagnosis and treatment outcomes in Ghana.[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin].Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.Recent advances in tuberculosis and nontuberculous mycobacteria lung disease.Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and Metaanalysis.[Standard therapy of tuberculosis].Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.Tuberculous peritonitis with infracarinal mass and elevated CA-125 in a 13-year-old girl.Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review.Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis.Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
P2860
Q24185762-A3716360-54E9-41E4-BCF4-03C94528896BQ24201325-A6CF5598-0EEF-4A77-8200-03C1B990680DQ26781111-83ABC5EA-A355-47DD-9C9C-6C2DC01936D5Q26801605-028DC073-71A0-402D-B08A-0715BDA948E3Q28389066-98D3B839-C4A5-4DB3-94D4-7FE825FB3637Q28551970-A2BAC791-7551-4979-A956-ABBBE04ED08CQ30239768-2F7DBF56-62F7-4D52-83FB-843F4BFE9506Q33797850-A029B976-31E1-4FBE-AC5E-859EDE2CB1DAQ33809243-8163474A-44F9-497F-BEF1-AAC5775A6524Q33823893-8131A966-1B3F-4AFB-9E82-6348453573E4Q34199723-45730BEB-6975-4060-BB83-54B072476106Q34519945-1A4F9F6F-FE3E-480A-B8EF-D71CEBD1AEA2Q35155471-4869805D-9A06-4F95-966A-9C74350E1B2EQ35657670-5EB3BC91-38FF-4A88-B147-5FA9BDE67C2DQ35714933-1B54A62F-C207-4328-AD19-96D1ADB9B08AQ35856542-7EFF4BC8-2148-4DA4-9A4E-B12D237E9584Q35944883-F61E73B5-A0CF-498E-B83B-042105F0E675Q36268159-77048C07-AB7D-494F-8C39-D5DB8431E480Q36325978-82728FB2-0B82-4B58-8CF1-0E83DB03EA3AQ36612483-BB442E25-5E47-43D5-B7C6-BA03E43BA3ABQ36811624-BBD80302-8D43-41E8-BC87-64D649CCC73EQ37152587-D25DF611-BFF9-43FE-A8BC-A8B16386FE49Q37724770-1C763154-E386-48F4-B5AA-E82E7ED77D1EQ38040155-E8D66282-2215-477A-85F4-3508A9320774Q38118312-228E930E-60AE-41ED-8730-CE214C81401EQ38958884-C23A6955-5805-4FB0-9668-FE3F498A81E8Q40921842-B0345DE5-32A5-488D-9244-C51977D4C662Q41657767-A0E10765-6C9D-4351-8B75-1904B4B46B7DQ42250760-3ED3E36E-B76F-4426-8BC8-2CD086567B77Q42376840-908AB05C-F6B8-4EF5-8BBF-502174D88FE6Q45741529-C0057F4E-D7BE-4BD2-BE48-209176B570E2Q50285140-B55360B2-E4B2-426B-93D5-4F8E22F151F4Q53669745-2D5B7DF6-9FCB-4A76-BB81-ED48ED05180AQ56334454-9F15C32B-3A19-43A5-A1D5-F3B33F536646
P2860
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efficacy and safety of a 4-dru ...... C randomized controlled trial.
@en
type
label
Efficacy and safety of a 4-dru ...... C randomized controlled trial.
@en
prefLabel
Efficacy and safety of a 4-dru ...... C randomized controlled trial.
@en
P2093
P356
P1476
Efficacy and safety of a 4-dru ...... C randomized controlled trial
@en
P2093
Amina Jindani
Christian Lienhardt
Don A Enarson
Gladys Anyo
Leen Rigouts
Marcos Burgos
Sang-Jae Kim
Sharlette V Cook
Study C Trial Group
P304
P356
10.1001/JAMA.2011.436
P407
P577
2011-04-01T00:00:00Z